7-hydroxy-5,11-dioxotetranorprostane-1,16-dioic acid and Crohn Disease

7-hydroxy-5,11-dioxotetranorprostane-1,16-dioic acid has been researched along with Crohn Disease in 1 studies

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	1 (100.00)	29.6817
2010's	0 (0.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Beauchamp, RD; Billheimer, DD; Coffey, RJ; Heslin, MJ; Johnson, JC; Joshi, PR; Merchant, NB; Morrow, JD; Ness, RM; Schmidt, CR; Schwartz, DA; Shrubsole, MJ; Washington, MK; Zheng, W	1

Other Studies

1 other study(ies) available for 7-hydroxy-5,11-dioxotetranorprostane-1,16-dioic acid and Crohn Disease

Article	Year
Urine PGE-M: A metabolite of prostaglandin E2 as a potential biomarker of advanced colorectal neoplasia. Clinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association, 2006, Volume: 4, Issue:11 Topics: Adenoma; Aged; Biomarkers, Tumor; Colonic Polyps; Colorectal Neoplasms; Crohn Disease; Cyclooxygenase 2; Female; Humans; Immunohistochemistry; Logistic Models; Male; Middle Aged; Prostaglandins; Sensitivity and Specificity	2006

Article

Year

Urine PGE-M: A metabolite of prostaglandin E2 as a potential biomarker of advanced colorectal neoplasia.

Clinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association, 2006, Volume: 4, Issue:11

Topics: Adenoma; Aged; Biomarkers, Tumor; Colonic Polyps; Colorectal Neoplasms; Crohn Disease; Cyclooxygenase 2; Female; Humans; Immunohistochemistry; Logistic Models; Male; Middle Aged; Prostaglandins; Sensitivity and Specificity

2006